Tumor-specific promoter-driven adenoviral therapy for insulinoma

Cellular Oncology

Volumn 39, Issue 3, 2016, Pages 279-286

  Tseng, Alan Wei Shun ^a,b   Chen, Chiachen ^a,c   Breslin, Mary B ^a,b,c   Lan, Michael S ^a,b,c  

^a The Research Institute for Children at Children's Hospital New Orleans   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Diana Helis Henry Medical Research Foundation   (United States)

Author keywords

Endocrine tumor; Gene therapy; INSM1; Insulinoma; Oncolytic

Indexed keywords

ADENOVIRUS VECTOR; CONDITIONALLY REPLICATING ADENOVIRUS; E1A PROTEIN; GANCICLOVIR; INSULINOMA ASSOCIATED 1; NEURONAL RESTRICTIVE SILENCER ELEMENT; THYMIDINE KINASE; TUMOR MARKER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; INSM1 PROTEIN, HUMAN; REPRESSOR PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; GENE MUTATION; HERPES SIMPLEX VIRUS; IN VITRO STUDY; IN VIVO STUDY; INSULINOMA; INTERNAL RIBOSOME ENTRY SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS REPLICATION; ADENOVIRIDAE; ANIMAL; DRUG SCREENING; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; ONCOLYTIC VIROTHERAPY; PANCREAS TUMOR; PROCEDURES; PROMOTER REGION; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; GANCICLOVIR; GENETIC THERAPY; GENETIC VECTORS; HUMANS; INSULINOMA; MICE; ONCOLYTIC VIROTHERAPY; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; THYMIDINE KINASE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84959131920     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-016-0274-8     Document Type: Article

References (12)

1. C. A. Proye, Endocrine tumours of the pancreas: an update. Aust. N. Z. J. Surg. 68, 90–100 (1998)
2. C. Yu, M. Wang, Z. Li, J. Xiao, F. Peng, X. Guo, Y. Deng, J. Jiang, C. Sun, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1. Cell. Oncol. 38, 173–181 (2015)
3. Y. Goto, M.G. DeSilva, A. Toscani, B.S. Prabhakar, A.L. Notkins, M.S. Lan, A novel human insulinoma-associated cDNA, IA-1, encodes a protein with zinc-finger DNA-binding motifs. J. Biol. Chem. 267, 15252–15257 (1992)
4. M. S. Lan, M. B. Breslin, Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation. FASEB J. 23, 2024–2033 (2009)
5. M. S. Gierl, N. Karoulias, H. Wende, M. Strehle, C. Birchmeier, The Zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells. Genes Dev. 20, 2465–2478 (2006)
6. H. Wildner, M. S. Gierl, M. Strehle, P. Pla, C. Birchmeier, Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 135, 473–481 (2008)
7. H. W. Wang, M. B. Breslin, C. Chen, V. Akerstrom, Q. Zhong, M. S. Lan, INSM1-promoter driven adenoviral HSV thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors. Human Gene Ther. 20, 1308–1318 (2009)
8. V. Akerstrom, C. Chen, M. S. Lan, M. B. Breslin, Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas. Cancer Gene Ther. 19, 828–838 (2012)
9. F. I. Moolten, J. M. Wells, R. A. Heyman, R. M. Evans, Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Human Gene Ther. 1, 125–134 (1990)
10. P. Whyte, K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, E. Harlow, Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334, 124–129 (1988)
11. W. C. Ch'ng, N. Abd-Aziz, M. H. Ong, E. J. Stanbridge, N. Shafee, Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-kappaB/IkappaBalpha pathway. Cell. Oncol. 38, 279–288 (2015)
12. H. Mizuguchi, Z. Xu, A. Ishii-Watabe, E. Uchida, T. Hayakawa, IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol. Ther. 1, 376–382 (2000)